Explore

Trendline Trendline
GSK's Bepirovirsen Shows Promising Cure Rates for Chronic Hepatitis B

GSK's Bepirovirsen Shows Promising Cure Rates for Chronic Hepatitis B

GSK's Bepirovirsen Shows Promising Cure Rates for Chronic Hepatitis B
Trendline Trendline
FDA Accepts BridgeBio's Application for Potential First Limb-Girdle Muscular Dystrophy Drug

FDA Accepts BridgeBio's Application for Potential First Limb-Girdle Muscular Dystrophy Drug

FDA Accepts BridgeBio's Application for Potential First Limb-Girdle Muscular Dystrophy Drug
Trendline Trendline
Marea Therapeutics to Present Phase 1 Study Results of MAR002 for Acromegaly at ENDO 2026

Marea Therapeutics to Present Phase 1 Study Results of MAR002 for Acromegaly at ENDO 2026

Marea Therapeutics to Present Phase 1 Study Results of MAR002 for Acromegaly at ENDO 2026
Trendline Trendline
Brenus Pharma's Immunotherapy for Colorectal Cancer Receives FDA IND Approval

Brenus Pharma's Immunotherapy for Colorectal Cancer Receives FDA IND Approval

Brenus Pharma's Immunotherapy for Colorectal Cancer Receives FDA IND Approval
Trendline Trendline
GSK and Ionis Achieve Breakthrough in Hepatitis B Treatment with Bepirovirsen

GSK and Ionis Achieve Breakthrough in Hepatitis B Treatment with Bepirovirsen

GSK and Ionis Achieve Breakthrough in Hepatitis B Treatment with Bepirovirsen
Trendline Trendline
Biopharma Companies Explore PD-(L)1×VEGF Bispecifics Beyond Lung Cancer

Biopharma Companies Explore PD-(L)1×VEGF Bispecifics Beyond Lung Cancer

Biopharma Companies Explore PD-(L)1×VEGF Bispecifics Beyond Lung Cancer
Trendline Trendline
Viridian Therapeutics to Engage in June 2026 Investor Conferences, Highlighting Autoimmune and Rare Disease Focus

Viridian Therapeutics to Engage in June 2026 Investor Conferences, Highlighting Autoimmune and Rare Disease Focus

Viridian Therapeutics to Engage in June 2026 Investor Conferences, Highlighting Autoimmune and Rare Disease Focus
Trendline Trendline
MedTherapy Expands CAR-T Manufacturing in India to Reduce Costs and Increase Accessibility

MedTherapy Expands CAR-T Manufacturing in India to Reduce Costs and Increase Accessibility

MedTherapy Expands CAR-T Manufacturing in India to Reduce Costs and Increase Accessibility
Trendline Trendline
InduPro Therapeutics Appoints Dr. Amanda J. Redig as Chief Medical Officer to Advance Oncology Programs

InduPro Therapeutics Appoints Dr. Amanda J. Redig as Chief Medical Officer to Advance Oncology Programs

InduPro Therapeutics Appoints Dr. Amanda J. Redig as Chief Medical Officer to Advance Oncology Programs
Trendline Trendline
Kura Oncology's New Cancer Drug Shows Promise, Potential $2 Billion Market Opportunity

Kura Oncology's New Cancer Drug Shows Promise, Potential $2 Billion Market Opportunity

Kura Oncology's New Cancer Drug Shows Promise, Potential $2 Billion Market Opportunity
Trendline Trendline
Nielsen BioSciences Completes Successful Phase 3 Trial for CANDIN in Wart Treatment

Nielsen BioSciences Completes Successful Phase 3 Trial for CANDIN in Wart Treatment

Nielsen BioSciences Completes Successful Phase 3 Trial for CANDIN in Wart Treatment
AP News AP News
Experimental hepatitis B drug might offer 'functional cure' for a subset of patients

Experimental hepatitis B drug might offer 'functional cure' for a subset of patients

New research suggests a first-of-its-kind drug for hepatitis B may let some patients stop treatment without showing signs of the dangerous liver virus